Andrew L. Rygiel
-
- Cancer Genomics and Diagnostics 4
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 4
- Colorectal Cancer Treatments and Studies 3
- Cancer Immunotherapy and Biomarkers 2
- Lung Cancer Research Studies 2
- PARP inhibition in cancer therapy 2
-
- Advanced Breast Cancer Therapies 7
- Lung Cancer Treatments and Mutations 5
- Statistics and Probability top 10%
Andrew L. Rygiel
12 papers receiving 332 citations
Peers
Comparison fields: 5 of 39
- Cancer Research 159
- Oncology 251
- Pulmonary and Respiratory Medicine 151
- Statistics and Probability 26
- Genetics 22
Countries citing papers authored by Andrew L. Rygiel
This map shows the geographic impact of Andrew L. Rygiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew L. Rygiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew L. Rygiel more than expected).
Fields of papers citing papers by Andrew L. Rygiel
This network shows the impact of papers produced by Andrew L. Rygiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew L. Rygiel. The network helps show where Andrew L. Rygiel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew L. Rygiel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 116 | |
| 2 | 2020 | 26 | |
| 3 | 2020 | 30 | |
| 4 | 2020 | 8 | |
| 5 | 2020 | 46 | |
| 6 | 2020 | 2 | |
| 7 | 2019 | 2 | |
| 8 | 2019 | 66 | |
| 9 | 2019 | 2 | |
| 10 | 2019 | 7 | |
| 11 | 2019 | 23 | |
| 12 | 2018 | 4 |
About Andrew L. Rygiel
Andrew L. Rygiel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 12 papers that have together received 332 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), Lung Cancer Treatments and Mutations (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Research Studies (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Cancer Research (159 citations), Oncology (251 citations) and Pulmonary and Respiratory Medicine (151 citations). Andrew L. Rygiel has collaborated with scholars based in United States. Frequent co-authors include Elizabeth Garrett‐Mayer, Susan Halabi, Pam K. Mangat, Richard L. Schilsky, Kaitlyn R. Antonelli, Eugene R. Ahn, Suanna S. Bruinooge, Nicole Butler, Carmen Calfa and Pamela Crilley. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.